RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$28.76
Tradestie Score
64
Market Cap
$2.89B
Revenue Growth
0.0%
Analyst Upside
+81.0%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.61
|
$3.09B | - | 54 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$34.81
|
$3.08B | - | 65 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$54.61
|
$3.02B | - | 67 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$65.73
|
$3.01B | - | 55 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$37.62
|
$2.85B | - | 58 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.40
|
$2.56B | 18.1 | 55 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
More RARE Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry